MMP2 and central nervous system cancer: As an example, in glioma, the downregulation of miR-383 stimulates AKT signaling and controls the expression of Matrix Metalloproteinase II (MMP2), through the regulation of IGF-1R, thereby controlling tumor cells invasiveness [146].